首页> 外文期刊>American Journal of Psychiatry and Neuroscience >In Differential Diagnosis of Dementia Application of Easy Z-score Imaging System in Single Photon Emission Computed Tomography Brain Perfusion Scan
【24h】

In Differential Diagnosis of Dementia Application of Easy Z-score Imaging System in Single Photon Emission Computed Tomography Brain Perfusion Scan

机译:简易Z评分成像系统在痴呆症的鉴别诊断中的应用

获取原文
           

摘要

Application of easy Z score imaging system (eZIS) on brain perfusion SPECT images for quantitative evaluation of rCBF has attempted to explore the differential diagnosis of dementia with various degenerative diseases and to evaluate discrimination of early Alzheimer's disease (AD) from other types of dementia. This retrospective study was done with various degenerative diseases that underwent brain perfusion SPECT using 99mTc ethyl cysteinate dimer were included. Brain perfusion SPECT was performed in 58 patients (M/F = 48/10) with mean age of 61.2±10.4 years (41-90). Decreased rCBF was observed in the area suspected early AD in 20 cases (34%) and in the frontal gyrus and insula in 10 cases (17%). And decreased rCBF was observed in occipital lobe and, precuneus, gyrus and posterior cingulate cortex in 8 cases (14%). Discrete areas of decreased rCBF were seen in 14 cases (24%) and the rest of 6 cases (11%) showed normal rCBF. Clinically suspected AD patients were divided into two groups on basis of MMSE score (group A, mild stage of AD, MMSE =20-26 and group B, moderate to severe stage of AD, MMSE=10-19). Mean MMSE and mean Z scores were 22.9±1.11 and 1.01±0.35 in group A (n = 12) while 17.56±0.96 and 2.62±0.59 in group B (n= 8). There was negative correlation between MMSE and eZIS score; r = - 0.69 in group A (p = 0.002); r = - 0.58 in group B (p = 0.019) and r = - 0.93 overall (p = 0.000). Quantification of rCBF with eZIS score was well associated with clinical MMSE scoring in this study group with clinical likelihood of having AD. In rest of the cases, SPECT findings and surface view analysis by eZIS, the affected area of decreased rCBF were consistent with clinically suspected different types of degenerative disease manifesting dementia.
机译:易Z评分成像系统(eZIS)在脑灌注SPECT图像上用于定量rCBF的尝试已尝试探索痴呆与各种退行性疾病的鉴别诊断,并评估早期阿尔茨海默病(AD)与其他类型痴呆的区别。这项回顾性研究是针对多种退化性疾病进行的,其中包括使用99mTc半胱氨酸乙酯二聚体进行脑灌注SPECT的研究。对58例患者进行了脑灌注SPECT(M / F = 48/10),平均年龄为61.2±10.4岁(41-90)。在怀疑的AD早期地区观察到rCBF降低20例(34%),额回和岛顶10例(17%)。枕叶,前突,回和扣带回皮层中的rCBF降低了8例(14%)。 14例(24%)出现离散区域的rCBF降低,其余6例(11%)则显示rCBF正常。临床疑似AD患者根据MMSE评分分为两组(A组,AD轻度阶段,MMSE = 20-26,B组,AD中度至重度阶段,MMSE = 10-19)。 A组(n = 12)的平均MMSE和Z均值分别为22.9±1.11和1.01±0.35(n = 12),而B组(n = 8)分别为17.56±0.96和2.62±0.59。 MMSE与eZIS评分之间呈负相关; A组中r =-0.69(p = 0.002); B组r =-0.58(p = 0.019),总体r =-0.93(p = 0.000)。在本研究组中,具有eZIS评分的rCBF定量与临床MMSE评分密切相关,临床上可能患有AD。在其余病例中,通过eZIS进行的SPECT检查结果和表面视图分析,rCBF降低的受影响区域与临床怀疑的不同类型的退化性疾病表现为痴呆相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号